机器人辅助放置盆腔组织扩张器用于前列腺癌生化复发放疗
OBJECTIVE: To present a robot-assisted surgical technique for overcoming challenges of a patient with prior pelvic surgeries and bowel in the radiation target. METHODS: A 72-year-old male required treatment for biochemically recurrent prostate cancer.…
要点
- 机器人辅助放置盆腔组织扩张器技术可行
- 可减少既往多次盆腔手术患者的放疗并发症
- 放疗后腹腔镜取出扩张器安全可行
核心结论
- 机器人辅助盆腔组织扩张器放置对多次盆腔手术患者可行,可能减少放疗并发症。
研究设计与样本
- 病例报告:72岁男性前列腺癌生化复发,既往机器人根治性前列腺切除术和膀胱根治性切除术。
主要发现
- 患者接受66 Gy调强放疗,耐受良好,无胃肠道不适。
- PSA最低值<0.02 ng/mL。
关键数值与推荐
- 2006年PSA 5.74 ng/mL,Gleason 3+3,行机器人根治性前列腺切除术,病理pT2aNx,切缘阴性。
- 2008年诊断肌层浸润性高级别乳头状尿路上皮癌,行机器人根治性膀胱切除术及回肠 conduit,病理pT2bN0。
- 2017年生化复发,PSA 0.27 ng/mL,盆腔CT示前列腺床后方小肠。
- 组织扩张器内注入330 cc生理盐水,用proline缝线固定。
- 调强放疗剂量66 Gy至前列腺床。
临床怎么用
- 对多次盆腔手术且肠管位于放疗靶区的患者,可考虑机器人辅助放置组织扩张器以分隔肠管。
局限性
- 单例病例报告,技术可行性和安全性需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To present a robot-assisted surgical technique for overcoming challenges of a patient with prior pelvic surgeries and bowel in the radiation target. METHODS: A 72-year-old male required treatment for biochemically recurrent prostate cancer. In 2006, he presented with Prostate-Specific Antigen (PSA) 5.74 ng/mL, Gleason 3 + 3 prostate cancer. He underwent a robot-assisted radical prostatectomy for pT2aNx adenocarcinoma with negative margins. In 2008, he was found to have muscle-invasive high-grade papillary urothelial carcinoma and underwent robot-assisted radical cystectomy and ileal conduit for pT2bN0 urothelial carcinoma. In 2017, he had prostate cancer biochemical recurrence, with a PSA of 0.27 ng/mL. Pelvic CT showed small bowel in his prostatic bed behind the pubic bone. A robot-assisted lysis of adhesions and placement of a tissue expander in the prostatic fossa was performed. Three robotic ports and 1 assistant port were utilized. The sigmoid and small bowel were displaced during lysis of adhesions. The deflated tissue expander was inserted through the midline trocar site, inflated intra-abdominally, and filled with 330 cc of saline. The tissue expander was secured with proline sutures in a dependent position. The patient subsequently underwent Intensity-modulated radiation therapy of 66 Gy to the prostatic fossa. Eleven days after finishing intensity-modulated radiation therapy, he underwent successful laparoscopic removal of the tissue expander. PSA nadir was <0.02 ng/mL. RESULTS: The patient tolerated intensity-modulated radiation therapy without complications. There were no gastrointestinal complaints following radiation therapy. CONCLUSION: Robotic placement of a tissue expander in patients who have undergone multiple pelvic surgeries is feasible and may reduce radiation morbidity.
引用
- Quarrier SO, Matloubieh JE, Wu G, et al. Robot-assisted Placement of Pelvic Tissue Expander for Radiation After Prostatectomy and Cystectomy for Treatment of Prostate Cancer Biochemical Recurrence. Urology. 2018. PMID: 30385261. doi:10.1016/j.urology.2018.09.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。